...
首页> 外文期刊>Diabetes technology & therapeutics >Genetic variants in peroxisome proliferator-activated receptor-gamma and retinoid X receptor-alpha gene and type 2 diabetes risk: a case-control study of a Chinese Han population.
【24h】

Genetic variants in peroxisome proliferator-activated receptor-gamma and retinoid X receptor-alpha gene and type 2 diabetes risk: a case-control study of a Chinese Han population.

机译:过氧化物酶体增殖物激活的受体-γ和类维生素A X受体-α基因的遗传变异和2型糖尿病风险:一项对中国汉族人群的病例对照研究。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: The serum levels of adiponectin are paradoxically decreased in obesity and may play important roles in the development of type 2 diabetes mellitus (T2DM). Potentially functional polymorphisms in the peroxisome proliferator-activated receptor-gamma (PPAR-gamma) and retinoid X receptor-alpha (RXR-alpha) genes may alter T2DM risks by increasing the human adiponectin promoter activity in cells. Therefore, we hypothesized that single nucleotide polymorphisms (SNPs) in PPAR-gamma and RXR-alpha were associated with risk of T2DM. To test this hypothesis, three potentially functional SNPs of PPAR-gamma and four of RXR-alpha with a minor allele frequency of >/= 0.05 in the Chinese Han population were identified from the National Center for Biotechnology Information dbSNPs database to evaluate their association with T2DM. METHODS: Polymerase chain reaction-restriction fragment length polymorphism was performed to test the genotypes in T2DM patients (n = 540) and normal controls (n = 604). RESULTS: The variant genotypes rs2920502CC, rs3856806CT, rs3856806CT/TT, and rs4240711AG/GG were associated with T2DM. Furthermore, the prevalences of haplotype GTC and CTG in PPAR-gamma and GTAC in RXR-alpha were less frequent in cases (17.1%, 2.6%, and 2.4%, respectively) than in controls (22.3%, 3.8%, and 6.6%, respectively), whereas GTGT in RXR-alpha was more frequent in cases (6.9%) than in controls (4.4%) (P < 0.05 for both two-sided chi(2) test and thousand times permutation tests). Patients with genotype CT/TT of rs3856806 and genotype AG/GG of rs4240711 had higher levels of serum adiponectin than those with the genotype CC and genotype AA (P = 0.026 and 0.021, respectively). Model X2 X5 X6 X7 (rs3856806, rs3132291, rs4240711, and rs4842194) was the best model with the highest test balanced accuracy (0.5764) (cross-validation consistency = 10/10) in the multifactor dimensionality reduction method. CONCLUSIONS: The PPAR-gamma and RXR-alpha gene variants associated with the development of T2DM in this study must be investigated in a larger population to reveal any potential effects on metabolism.
机译:背景:肥胖者的血清脂联素水平反常下降,可能在2型糖尿病(T2DM)的发生中起重要作用。过氧化物酶体增殖物激活受体-γ(PPAR-γ)和类维生素A X受体-α(RXR-α)基因中潜在的功能多态性可能会通过增加细胞中人脂联素启动子的活性来改变T2DM风险。因此,我们假设PPAR-γ和RXR-α中的单核苷酸多态性(SNP)与T2DM的风险有关。为了验证这一假设,从国家生物技术信息中心的dbSNPs数据库中鉴定了中国汉族人群中三个PPAR-γ潜在功能性SNP和RXR-alpha四个等位基因频率> / = 0.05。 T2DM。方法:采用聚合酶链反应-限制性片段长度多态性检测T2DM患者(n = 540)和正常对照(n = 604)的基因型。结果:变异基因型rs2920502CC,rs3856806CT,rs3856806CT / TT和rs4240711AG / GG与T2DM相关。此外,与对照组(22.3%,3.8%和6.6%)相比,PPAR-γ中单倍型GTC和CTG的患病率以及RXR-alpha中的GTAC的患病率(分别为17.1%,2.6%和2.4%)较少。 ),而RXR-alpha中GTGT的发生率(6.9%)比对照组(4.4%)要高(双面chi(2)测试和千次置换测试的P <0.05)。 rs3856806基因型CT / TT和rs4240711基因型AG / GG的患者的血清脂联素水平高于CC基因型和AA基因型的患者(分别为P = 0.026和0.021)。在多因素降维方法中,模型X2 X5 X6 X7(rs3856806,rs3132291,rs4240711和rs4842194)是测试平衡精度最高(0.5764)(交叉验证一致性= 10/10)的最佳模型。结论:在这项研究中,与T2DM发展有关的PPAR-γ和RXR-alpha基因变异必须在更大的人群中进行研究,以揭示对代谢的任何潜在影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号